Los Angeles, CA – According to filings with the U.S. Securities and Exchange Commission, Bionaut Labs is raising $43,000,000.00 in new funding. Sources indicate as part of senior management Chairman, Aviad Maizels played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Bionaut Labs
Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality. By creating a new medical modality of remote-controlled micro-robots called Bionauts, the company can transform the way the biopharmaceutical industry develops treatments, allowing them to engineer the therapeutic index for efficacy.

To learn more about Bionaut Labs, visit http://www.bionautlabs.com/

Contact:
Aviad Maizels, Chairman
425-268-6252

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved